One of the most important things a patient can do is see a true MPN Specialist, the … Learn More

MPN Information and Research Hub
Part 4 in a New Series: "Addressing MPN Symptoms" Prevalence of Chronic Pain and High-Impact Chronic Pain in Cancer Survivors in the United States Jiang C, Wang H, … Continue Reading
Part 3 in a New Series: "Addressing MPN Symptoms" Check out the entire series (2022 update) Over the Counter Combo of Zyrtec and Zantac helping PV … Continue Reading
MPN Chronicles Podcast - 03, PV Reporter, Day 3, 2nd Trip to ER in 3 Days by David Wallace Chest pain continued to worsen after 1st trip to the ER, 2 days earlier. … Continue Reading
by David Wallace As some MPN patients are aware of firsthand, there are a number of autoimmune diseases that may run concurrently with the condition – while these … Continue Reading
by Marcy Worthington, Charla Billick, Christine Kelly Kennedy and multiple contributions from members of Facebook Support Group When we have an appointment scheduled … Continue Reading
How Can I Beat the Itchies? contributed by Paul Jaeger I was suffering from itching (pruritis) almost 10 years before my Polycythemia Vera was diagnosed. It's the … Continue Reading
PV Reporter was created to provide “easy access” to pertinent information on Polycythemia Vera (PV), Essential Thrombocythemia (ET) and Myelofibrosis (MF).
One of the most important things a patient can do is see a true MPN Specialist, the … Learn More
The Blog Page provides timely, relevant news items, research reports, “‘patient stories”, … Learn More
An Overview of Myeloproliferative Neoplasms A myeloproliferative neoplasm (MPN) … Learn More
MPN Search - Myeloproliferative Neoplasm (MPN) Custom Search of "Authority Sites" MPN … Learn More
This Podcast will cover many elements of my Polycythemia Vera (PV) journey, from the day … Learn More
Our fellow MPN Patients share their trials and tribulations with Polycythemia Vera, … Learn More
Would you like to speak with an Information Specialist to obtain information and resources … Learn More
This group is for people with myeloproliferative neoplasms (MPNs). MPNs include … Learn More
Search for MPN Clinical Trials that may help you find new treatments and medical approaches for your myelofibrosis (MF), polycythemia vera (PV) or essential thrombocythemia (ET).
ClinicalTrials.gov is difficult to use for patients, as it is primarily a resource for doctors and clinicians. Our Clinical Trial Finder restructures the trial information - providing "easy access" while improving patient's understanding of the trial.
Abbvie is the sponsor. Navitoclax in phase 3 clinical trial. Study of Oral Navitoclax Tablet In Combination With Oral Ruxolitinib Tablet When Compared With Oral Ruxolitinib Tablet To Assess Change … Learn More
Abbvie is the sponsor. Navitoclax in phase 3 clinical trial. Study of Oral Navitoclax Tablet in Combination With Oral Ruxolitinib Tablet to Assess Change in Spleen Volume in Adult Participants With … Learn More
Abbvie is the sponsor. Navitoclax in phase 1 clinical trial. A Study Evaluating Safety and Tolerability, and Pharmacokinetics of Navitoclax Monotherapy and in Combination With Ruxolitinib in … Learn More
by Christina T. Loguidice, OncLive Prevention and mitigation of cardiovascular events, such as thrombohemorrhagic complications, have been the main goal of treatment development for patients with essential thrombocythemia and polycythemia vera. Prevention and mitigation of cardiovascular events, such as thrombohemorrhagic complications, have been the main goal of treatment development for patients with essential thrombocythemia (ET) […]
by David Wallace Transcript | Can Polycythemia Vera (PV) Patients Live a Normal Lifespan? David Wallace: So you had several important abstracts and one that our listeners with PV will be excited about. So tell us about the potential for normal life expectancy in PV. Dr. Abu-Zeinah: So this a project was inspired by our […]
Someone around the world is diagnosed with blood cancer every 35 seconds (every 3 minutes in the U.S.)… but what does this mean? With over 137 different types of blood cancer and blood disorders, it can be difficult to understand what exactly is meant by the term ‘blood cancer.’ This video uses a medical approach […]
Physicians should consider measuring anti-endothelial cell antibodies in patients with polycythemia vera, the investigators suggested. A new analysis of anti-endothelial cell antibodies (AECAs) in patients with polycythemia vera (PV) suggests that autoimmunity may be one mechanism by which thrombosis develops. Abstract Polycythemia vera (PV) causes thrombosis. Erythrocytosis and cell adhesiveness are responsible for thrombosis. JAK2V617F causes inflammation […]
Abstract Philadelphia-negative myeloproliferative neoplasms (MPNs) occur when there is over-production of myeloid cells stemming from hematopoietic stem cells with constitutive activation of JAK/STAT signaling, with JAK2V617F being the most commonly occurring somatic driver mutation. Chronic inflammation is a hallmark feature of MPNs and it is now evident that inflammation is not only a symptom of MPN but […]
PV Reporter was created to provide “easy access” to pertinent information on Polycythemia Vera (PV), Essential Thrombocythemia (ET) and Myelofibrosis (MF). These disorders are Myeloproliferative Neoplasms (MPNs), a closely related group of blood cancers where the bone marrow cells that produce the body’s blood cells function and develop abnormally.
If you are a newly diagnosed patient or researching MPNs, make PV Reporter your starting point. While many existing MPN websites provide excellent content, they tend to be internally focused or lack external search capabilities. PV Reporter solves that problem with MPN Search, a “custom search engine” retrieving exactly the information you are looking for!